Vanda Pharmaceuticals Inc. is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. VNDA has around 12.1M shares in the U.S. ETF market. The largest ETF holder of VNDA is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.32M shares. Investors may also find of interest that the ETF with the largest allocation to VNDA stock is Invesco Dynamic Pharmaceuticals ETF (PJP), with a portfolio weight of 2.77%. On average, U.S. ETFs allocate 0.24% of VNDA to their portfolios.
Additionally, VNDA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VNDA as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.